Latest News for: tumor hypoxia

Edit

ImmunoGenesis Doses First Patient in Phase 1/2 Clinical Trial of IMGS-101 in Combination With Balstilimab ...

The Galveston Daily News 07 Mar 2025
IMGS-101 is the only known reducer of solid tumor hypoxia, offering the potential to enhance the efficacy of immunotherapy ....
  • 1
×